Brief: Medexus Provides Update On Treosulfan NDA Resubmission, Provides Business Update

Medexus Pharmaceuticals

19/09/2022 13:24

Sept 19 (Reuters) - Medexus Pharmaceuticals Inc  MDP.TO :
    * MEDEXUS PROVIDES UPDATE ON TREOSULFAN NDA RESUBMISSION AND
PROVIDES BUSINESS UPDATE
    * MEDEXUS PHARMACEUTICALS INC - FDA REQUESTS FURTHER
INFORMATION
FROM MEDAC, CONTINUES TO ENGAGE WITH TREOSULFAN NDA

Source text for Eikon:  ID:nGNX4H9Nbk 
Further company coverage:  MDP.TO 

 ((Reuters.Briefs@thomsonreuters.com;))